ABBOTT LABORATORIES - Common Stock (ABT)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Number of holders
1,478
Total 13F shares, excl. options
1,033,961,965
Shares change
+5,838,924
Total reported value, excl. options
$50,752,165,358
Value change
+$294,425,750
Put/Call ratio
133%
Number of buys
562
Number of sells
-692
Price
$49.08

Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2015

1,581 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q2 2015.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,478 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,033,961,965 shares of 1,740,239,592 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (90,839,559 shares), STATE STREET CORP (61,400,890 shares), BlackRock Institutional Trust Company, N.A. (38,985,523 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (32,991,495 shares), Bank of New York Mellon Corp (29,437,734 shares), JPMORGAN CHASE & CO (25,741,004 shares), NORTHERN TRUST CORP (22,682,216 shares), JENNISON ASSOCIATES LLC (21,072,558 shares), BlackRock Fund Advisors (19,947,072 shares), and GOLDMAN SACHS GROUP INC (18,215,388 shares).
This table shows the top 1,478 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.